B D Evans

Clinical aspects of a phase I trial of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent

Michael B. Jameson, Paul Thompson, Bruce C. Baguley et al. · British Journal of Cancer · 2003 · 139 citations · Full text

Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.

Ulrich H. Rudofsky, B D Evans, S L Balaban et al. · PubMed · 1993 · 131 citations

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer.

David Pérez, V.J. Harvey, Bridget A. Robinson et al. · Journal of Clinical Oncology · 1991 · 116 citations

Cardiovascular Toxicity, Advanced Breast Cancer, Heart Failure +15

Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.

B D Evans, K. Srujan Raju, A H Calvert et al. · PubMed · 1983 · 114 citations

Tumoral Pathology, Medicine, New Platinum Analog +12

Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

Ian E. Smith, B D Evans, M. Gore et al. · Journal of Clinical Oncology · 1987 · 100 citations

World Health Organization, Pathology, Multimodality +21